Stable powder formulation containing an anticholingeric agent

Patent metadata

Field	Value
Publication number	US-2016263121-A1
Application number	US-201615157695-A
Country	US
Kind code	A1
Filing date	May 18, 2016
Priority date	Nov 22, 2006
Publication date	Sep 15, 2016
Grant date	—

Abstract

A spray-dried powder formulation comprising particles that contain the following components i) to iii): i) anticholinergic agents, in particular at least one compound of formula 1, in which X − is a negatively charged anion, ii) at least one embedding material selected from the group consisting of mono- or disaccharides, oligosaccharides, polymers, sugar alcohols and cholesterol, and iii) an organic, physiologically acceptable, sterically demanding acid, selected from the group consisting of ascorbic acid, a monovalent, divalent or trivalent carboxylic acid, with the exception of amino carboxylic acids, to preferably fumaric acid, oxalic acid, or diacetic acid, and a fruit acid or culinary acid, preferably citric acid, tartaric acid, malic acid, lactic acid, acetic acid, α-hydroxycaprylic acid or gluconic acid.

First claim

1 . A spray-dried powder formulation comprising particles that contain the following components i) to iii):
i) a compound of formula 1

wherein X − is a negatively charged anion;
ii) as an embedding material lactose;
iii) an organic, physiologically acceptable, sterically demanding acid selected from ascorbic acid and a mono-, di- or trivalent carboxylic acid with the exception of the aminocarboxylic acids, wherein the acid is in a concentration such that the sprayable solution has a pH of ≦4.

2 . The spray-dried powder formulation according to claim 1 , wherein the particles of the spray-dried powder formulation have a mean aerodynamic diameter of less than or equal to 10 μm and are suitable for administration using an inhaler.

3 . The spray-dried powder formulation according to claim 1 , wherein the compound of formula 1 is in a concentration of between 0.05% and 1%

4 . The spray-dried powder formulation according to claim 1 , wherein the organic, physiologically acceptable, sterically demanding acid according to iii) is selected from citric acid, tartaric acid, malic acid, lactic acid, acetic acid, α-hydroxycaprylic acid, gluconic acid, fumaric acid, oxalic acid, and succinic acid.

5 . The spray-dried powder formulation according to claim 1 , wherein the organic, physiologically acceptable, sterically demanding acid according to iii) is citric acid.

6 . The spray-dried powder formulation according to claim 1 , wherein the spray-dried powder formulation additionally contains the salt of an organic, physiologically acceptable, sterically demanding acid according to iii) selected from ascorbate, the salt of a fruit or culinary acid, and the salt of a mono-, di- or trivalent carboxylic acid, with the exception of the salts of the aminocarboxylic acids.

7 . The spray-dried powder formulation according to claim 1 , wherein the spray-dried powder formulation additionally contains the salt of an organic, physiologically acceptable, sterically demanding acid according to iii) selected from the salt of a fruit or culinary acid selected from citrate, tartrate, malate, lactate, acetate, α-hydroxycapronate, and gluconate or the salt of a mono-, di- or trivalent carboxylic acid, with the exception of the salts of the aminocarboxylic acids, selected from the fumarate, oxalate, and succinate.

8 . The spray-dried powder formulation according to claim 7 , wherein the spray-dried powder formulation contains citrate as the salt of the organic, physiologically acceptable, sterically demanding acid according to iii).

9 . The spray-dried powder formulation according to claim 7 , wherein the salt of the organic, physiologically acceptable, sterically demanding acid is an alkali metal salt, an alkaline earth metal salt or a zinc salt.

10 . The spray-dried powder formulation according to claim 1 , in which in the compound of formula 1 according to i), X − is an anion selected from the chloride, bromide, iodide, sulphate, phosphate, methanesulphonate, nitrate, maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate, and p-toluenesulphonate.

11 . The spray-dried powder formulation according to claim 10 , in which in the compound of formula 1 according to i), X − is bromide.

12 . The spray-dried powder formulation according to claim 1 , wherein the embedding material according to ii) is a mono- or disaccharide selected from glucose, saccharose, fructose, maltose, lactose, cellulose, and trehalose.

13 . The spray-dried powder formulation according to claim 1 , wherein the embedding material according to ii) is an oligosaccharide selected from oligomaltose, oligofructose, cyclodextrins, dextrins, and oligosaccharose.

14 . The spray-dried powder formulation according to claim 1 , wherein the embedding material according to ii) is a polymer selected from among inulin, alginate, maltodextrin, starch, cellulose, polyvinylpyrrolidone (PVP), gelatine, chitosan, dextranes, pectins, gum arabic, polylactides, poly(lactide-co-glycolides), and polyvinylalcohols.

15 . The spray-dried powder formulation according to claim 1 , wherein the embedding material according to ii) is a sugar alcohol selected from among mannitol, xylitol, and sorbitol.

16 . The spray-dried powder formulation according to claim 1 , wherein the organic, physiologically acceptable, sterically demanding acid according to iii) is citric acid and the citric acid is added to the sprayable solution containing the compound according to i), and the at least one embedding material according to ii) in a concentration such that the pH of the solution is ≦4.

17 . A powder formulation that contains particles comprising together the following components i) to iii), obtained by a process comprising the following steps:
a) preparing a solution comprising components i) to iii):
i) a compound of formula 1:

wherein X − is a negatively charged anion, and the compound of formula 1 is in a concentration of between 0.05% and 1%,
ii) at least one embedding material selected from among mono- or disaccharides, oligosaccharides, polymers, sugar alcohols and cholesterol, and
iii) an organic, physiologically acceptable, sterically demanding acid selected from ascorbic acid, a fruit or culinary acid, and a mono-, di-, or trivalent carboxylic acid, with the exception of the aminocarboxylic acids, in a suitable solvent;

b) atomizing the solution from step a) in a hot air current;
c) drying the atomized solution from step b) to form a powder containing particles; and
d) separating off the powder from step c) using a cyclone or filters,

wherein the particles of the spray-dried powder formulation have a mean aerodynamic diameter of less than or equal to 10 μm and are suitable for administration using an inhaler.

18 . The powder formulation according to claim 17 , wherein in step a) a solution is prepared which contains as the organic, physiologically acceptable, sterically demanding acid according to iii) a fruit or culinary acid selected from citric acid, tartaric acid, malic acid, lactic acid, acetic acid, α-hydroxycaprylic acid, and gluconic acid or a mono-, di-, or trivalent carboxylic acid, with the exception of the aminocarboxylic acids, selected from fumaric acid, oxalic acid, and succinic acid.

19 . The powder formulation according to claim 17 , wherein in step a) a solution is prepared which contains citric acid as the organic, physiologically acceptable, sterically demanding acid according to iii).

20 . The powder formulation according to claim 17 , wherein in step a) a solution is prepared which additionally contains the salt of an organic, physiologically acceptable, sterically demanding acid according to iii) selected from ascorbate, the salt of a fruit or culinary acid and the salt of a mono-, di-, or trivalent carboxylic acid, with the exception of the aminocarboxylic acids.

21 . The powder formulation according to claim 20 , wherein in step a) a solution is prepared which contains as an additional salt of an organic, physiologically acceptable, sterically demanding acid according to iii) the salt of a fruit or culinary acid selected from the citrate, tartrate, malate, lactate, acetate, α-hydroxycapronate, and gluconate or the salt of a mono-, di-, or trivalent carboxylic acid, with th

Assignees

• Boehringer Ingelheim Int

Inventors

• Trunk Michael
• Weiler Claudius
• Pieroth Werner

Classifications

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61P11/16

  Central respiratory analeptics · CPC title

• A61K9/1623

  Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules · CPC title

• A61P11/06

  Antiasthmatics · CPC title

• A61K9/4858

  Organic compounds · CPC title